This doesn’t Ad up, Novo Nordisk sues Eli Lilly in GLP-1 advertising feud The clash between pharma titans Novo Nordisk and Eli Lilly just escalated from the pharmacy counter to the courtroom.Novo Nordisk Inc. filed a lawsuit in the U.S. District Court for the District...
Doing the slide, Netflix stocks is sliding after missed analyst expectations Streaming giant Netflix led Friday’s decliners, sliding 9.3% in premarket trading after its quarterly results failed to impress investors despite modest earnings beat.The company reported...
Match made in heaven, Marriott and Coca-Cola strike global beverage supply agreement Marriott International (MAR) and The Coca-Cola Company (KO) announced a global beverage agreement that will place Coca-Cola brands across Marriott’s hotel portfolio worldwide,...
Changing places, Alphabet to replace Verizon in blue-chip Dow Jones Industrial Average S&P Dow Jones Indices on Tuesday said Alphabet stock will replace Verizon in the blue-chip Dow Jones Industrial Average effective June 29. Shares of Google rose 0.3% in pre-open...
Wasting no time, SpaceX to acquire Cursor in $60 billion all-stock deal Space Exploration Technologies Corp. (SPCX) has entered into a merger agreement to acquire Anysphere, Inc., the company behind the AI coding tool Cursor, in an all-stock transaction valuing Cursor...
Approval over the pond, Bristol Myers Squibb gains EU approval for Opdivo combination in lymphoma Bristol Myers Squibb (BMY) received European Commission approval for Opdivo (nivolumab) in combination with doxorubicin, vinblastine and dacarbazine (AVD) for treating...
